Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04625699
Title Study of Durvalumab + Tremelimumab in NSCLC Patients After Adjuvant Treatment
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Catherine Shu
Age Groups: senior | adult
Covered Countries

Additional content available in CKB BOOST